HIV and CKD in the Tenofovir Era: A Prospective Parallel-Group Cohort Study From Tanzania
PLWH receiving tenofovir disoproxil fumarate-based ART had a very high incidence of CKD and rapid eGFR decline. Conversely, albuminuria stabilized with ART use. Expanding access to less-nephrotoxic ART, such as tenofovir alafenamide, is urgently needed throughout sub-Saharan Africa.
Authors
- Said Kanenda
- Bernard Desderius
- Bazil Baltazar Kavishe (ORCID: https://orcid.org/0000-0003-4839-4590)
- Megan Willkens (ORCID: https://orcid.org/0009-0003-8184-1302)
- Serena P. Koenig (ORCID: https://orcid.org/0000-0001-7464-275X)
- Sri Lekha Tummalapalli (ORCID: https://orcid.org/0000-0002-6513-8460)
- Robert N. Peck (ORCID: https://orcid.org/0000-0002-4526-2480)
- Nicholas L S Roberts (ORCID: https://orcid.org/0000-0001-7238-8559)
- Grace Ruselu (ORCID: https://orcid.org/0009-0002-8101-1598)
- Myung‐Hee Lee (ORCID: https://orcid.org/0000-0002-9588-5408)
- Ladius Rudovick (ORCID: https://orcid.org/0000-0003-2012-4054)
- Salama Fadhil
Institutions
- Brigham and Women's Hospital (US)
- Cornell University (US)
- Center for Global Health (US)
- Mwanza Intervention Trials Unit (TZ)
- Bugando Medical Centre (TZ)
- National Institute for Medical Research (TZ)
- Weill Cornell Medicine (US)
- The Rogosin Institute (US)
Publication Details
- Journal
- Kidney Medicine
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.xkme.2024.100937
- Citations
- 1
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Brigham and Women's Hospital
- National Institutes of Health
- College of Veterinary Medicine, Cornell University
- Weill Cornell Medical College
- National Heart, Lung, and Blood Institute
- Fogarty International Center